New heart pump trial offers hope for advanced heart failure patients
NCT ID NCT06907017
First seen Feb 16, 2026 · Last updated May 10, 2026 · Updated 12 times
Summary
This study tests a new heart pump (CorWave LVAS) in 20 people with advanced heart failure. The pump helps the heart pump blood when medicines are no longer working. The main goal is to see if the device is safe and helps people survive for at least 30 days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayside Health
RECRUITINGMelbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St Vincent's Hospital Sydney
RECRUITINGSydney, New South Wales, 2010, Australia
Conditions
Explore the condition pages connected to this study.